Meet Our Leadership Team
Co-founder and Chief Executive Officer
Anju Mathew is CEO and co-founder of OncoLens. Most recently, she was the head of technology and innovation at McKesson’s Medical Surgical business unit where she led the development and launch of several successful tools and business partnerships positioned to take costs out of our healthcare system.
Prior to her role at McKesson Medical Surgical, Anju was part of McKesson’s corporate strategy group. She was also co-founder and executive at LumaMed, a medical device company focused on cancer imaging. Prior to LumaMed, she worked with Thomson-Reuters, A. T. Kearney, IBM and i2 Technologies.
Anju has an MBA from Northwestern University’s Kellogg School of Management and Bachelor’s in Industrial Engineering from the Indian Institute of Technology. She is a member of the Atlanta Technology Angels group and a member of the board of directors for Illuma Care Connections, headquartered in Atlanta.
In her free time, Anju enjoys spending time with her husband, son, daughter and dog, Lexi. She enjoys going on long walks, watching movies and traveling around the world.
Co-founder and Chief Medical Officer
Lijo is a board certified Hematologist and Medical Oncologist with Atlanta Cancer Care and practices at DeKalb Medical Center and Southern Regional Medical Center in the Atlanta area. He has been named to the Atlanta Magazine’s list of top doctors from 2013 to 2018.
He has published numerous articles outlining his research in colorectal, genitourinary, hematologic cancers and melanoma and has also presented extensively at the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH) and at the American Society of Bone Marrow Transplantation (ASBMT). He is a member of the American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH). He has over six years of research experience as a Principal Investigator and Sub Investigator in numerous Phase two to four trials.
Lijo completed his fellowship in Hematology and Medical Oncology from The Mayo Clinic, Rochester MN and his residency from Advocate Illinois Masonic Medical Center, Chicago. In his free time, Lijo loves to spend time with his family, refine his culinary skills and beat the bad guys on the X-box.
Chief Technology Officer
Eric is a recognized technologist with substantial software leadership experience in both large company and start-up environments. Spending 17 years at NCR Corporation, Eric began his career focused on customers and end users as he led product development within NCR’s retail division.
Shortly after arriving in Atlanta, Eric transitioned into the Healthcare industry attending early BlueButton discussions at the White House and leading software, hardware, and regulatory organizations at SoloHealth, where the company successfully launched self-service Health & Wellness kiosks in thousands of Walmart’s across the United States.
Eric earned a Bachelor of Science degree from Hofstra University, holds several software and hardware patents, and has served on the TAG Retail board for several years.
In his free time, Eric and his wife enjoy hiking, cycling and competing in triathlons.
VP of Business Development
Kirk has a life sciences background with experience related to the pharmaceutical, biotechnology, nanotechnology, diagnostic, medical device and digital health industries. Kirk has a broad background encompassing leadership, sales, sales excellence coaching and training, business development, global marketing, lobbying and managed markets. Currently, Kirk also serves as a Start-Up Catalyst for new and emerging healthcare and health IT start-ups at the Advanced Technology Development Center (ATDC) incubator housed at the Georgia Tech in Atlanta, GA.
Kirk served in various positions of increasing responsibility for the following companies in the pharma/ biotech sector: Inventiv Health, Zogenix, Takeda, Janssen Biotech and Pfizer. Therapeutic categories included pain management, central nervous system disorders, oncology, hematology, cardiology and endocrinology. Kirk was also a Global Business Development Executive for the NanoProfessor & NanoGuardian divisions of NanoInk, a private equity funded start-up company commercializing research-based nanotechnology from Northwestern University. Kirk marketed innovative anti-counterfeiting solutions to pharmaceutical, defense, consumer and medical device industries in the US, EU and Asia. He served as a Board Member of the International Authentication Association (IAA), which monitored and provided guidance regarding authentication techniques and counterfeiting trends.
Kirk continues to serve as a Together.health Steering Committee Member, Coulter Foundation Oversight Committee Member, TAG Health Board Member, GA BIO Commercialization Committee Member, Metro Atlanta Chamber of Commerce BioScience Council Member and a Patientory Board Observer. Kirk holds a B.A. in Economics from Florida A&M University.
VP of Operations and Customer Success
Ed is responsible for day to day operations of Oncolens, with a focus on ensuring successful customer onboarding and continued success in using our solution.
Previous to this role, Ed held various client facing positions at Ingenious Med, a medical professional fee charge capture software solution company. As the VP of Implementations and Training, Ed played a key role in scaling the company through an explosive growth period. He also held positions as the VP of Specialty Solutions and Strategic Account Manager.
Prior to working at Ingenious Med, Ed served in the United States Air Force where he was a C-130 pilot. He also served in various senior staff positions including at a US Embassy abroad and with the Space Shuttle Program.
Ed has a Master’s Degree in Management from Embry Riddle Aeronautical University and a Bachelor of Science from The United States Air Force Academy. He is a certified Project Management Professional and member of the Project Management Institute (PMI) and the American Health Information Management Association (AHIMA).
In his free time, Ed enjoys spending time with his wife trying to keep up with their teenagers, fly fishing, woodworking, and exercising.
VP of Engineering
Robert's focus is a blend of building mission critical enterprise systems while growing and nurturing highly performing engineering teams in environments where failure is not an option.
His background ranges from start-ups to Fortune 500 environments including development and exit of ExpressYard, a leading SaaS platform in the transportation sector now homed at GE Transportation / Wabtec and recently the rapid growth of teams and systems at Kabbage, Inc in the FinTech sector.
He has a Bachelor of Science degree from University of Michigan and in his free time enjoys photography and spending time with his growing family.
Customer Success Manager
Prior to joining OncoLens, Ebony was a Certified Tumor Registrar at Northside Hospital Cancer Institute in Atlanta, Georgia as well as NYU Winthrop Hospital in Mineola, New York. As a CTR at Northside Hospital she specialized in the process development for the adherence to the Commission on Cancer Survivorship Standard.
Ebony is an active member of the National Cancer Registrars Association (NCRA) where she serves on the Informatics Committee and she is also an active member of the Georgia Tumor Registrars Association (GATRA) where she most recently served as Treasurer and Publicity Chair. In 2018, she was awarded the NCRA Outstanding New Professional Award for her accomplishments and endeavors in the cancer registry profession.
Prior to becoming a CTR, Ebony worked in customer service for various companies including T-Mobile and Twelve South and was also an AppleCare technical support provider at Apple, Inc.
In her spare time Ebony enjoys spending time with her husband and two children. She enjoys traveling and attending music concerts.
Meet Our Board of Directors and Advisors
Mr. Sarath Degala is a Vice President, leading healthcare Investments, for BIP Capital since 2017. Prior to joining BIP Capital, Mr. Degala served as CEO at Baylor Scott & White Health system in Frisco, TX. Before assuming his role at Baylor Scott & White, Mr. Degala served as the Chief Development Officer for Surgery Partners (NASDAQ: SGRY) located in Nashville, TN in 2016-2017.
He held several executive positions at Tenet Healthcare (NYSE:THC) including Chief Strategy Officer. In this role, he was responsible for Strategy and M&A for the largest region within Tenet ($800M EBITDA) which included 24 acute care facilities, 91 Ambulatory Surgical Centers, 22 urgent care facilities and 11 free standing emergency rooms. Prior to Tenet, Sarath held multiple executive roles at WellStar Health System and Ascension Health.
Mr. Degala has served as a member of the Board of Directors of Reach Health and PriorAuthNow. Mr. Degala received a Bachelor's degree in Health Services Administration, a Master's degree in Health Administration from the University of Central Florida and a Master's degree in Business Administration from Goizueta Business School at Emory University in Atlanta, Georgia.
Bill Midgette retired from Porex Corporation in 2016, after serving as the President and CEO for 13 years, and following two successful leveraged buyouts. During his tenure, Porex realized several successful M&A transactions, on both the buying and selling side, on its way to becoming the global leader in advanced porous polymer solutions. Midgette has served as Managing Director for subsidiary companies in Japan, China, Germany, U.K. and Malaysia, as well as holding advisory board positions in industry associations in the U.S. and internationally.
Previously, Midgette spent 18 years with C.R.Bard, Inc., where he held several senior executive positions including as President of Bard International, Inc., Bard Medical, and Bard Japan Ltd. During his tenure, he led the investment in, and development and commercialization of market changing products in the cardiovascular, endovascular and urology markets.
Over his career, Midgette has executed on the development and commercialization of new product technologies, in bioscience, medical and advanced materials markets, through licensing, strategic partnerships, joint ventures, and acquisitions. He is the holder of two patents on commercialized medical device technologies, with a third pending.
Midgette now leads Fairburn Equity partners, advises early stage technology companies, and is on the Board of Carbice Corporation. Bill received a Bachelor of Environmental Studies Degree at the University of Waterloo. Bill is also a member of the Board of Directors of Carbice Corp, Quest Renewables, and Atlanta Technology Angels.
Carla Balch is a tenured President and CEO with expertise building infrastructure and growth in the healthcare technology market by spearheading pioneering oncology software. Carla's motivation to create ground-breaking products and innovative market strategy is rooted in the belief every patient deserves the best care available and every employee deserves a great culture. The most successful strategic partnerships share this core motivation.
Carla is the CEO of TransMed Systems, Inc., a technology company specializing in data aggregation, enhancement and utility along with enterprise software for the benefit of improving healthcare clinical trials.
Previously, Carla served as President of Nantcare, a California-based oncology clinical trials and technology company. As President and CEO of Altos Solutions, the first web-based oncology electronic medical record and big data company, Carla led its sale to Flatiron Health, a Google-Ventures backed organization that was acquired by Roche for $2b.
Carla developed her passion for patients and technology as Director of Product Development and Sr. Financial Operations Manager of SOS/ACORN, an oncology research company and community research network formed from West Cancer Center in Memphis, TN.
A graduate of University of Memphis with a cum laude Master of Science in Psychology, Carla's commitment to the Healthcare community includes serving as Host of the Cancer Center Business Summit since 2004, and serving as a Healthcare Board Member of the Federal Reserve Bank in St. Louis, MO. She mentors start-up companies and has co-founded two new healthcare ventures. She lives in Memphis and enjoys traveling with her husband Lendon, a CTO and talented musician/songwriter.
Jane is Assistant Director at ATDC. Jane returned to ATDC as a Startup Catalyst, having started her career here many years ago. She then moved into venture capital and investment banking both in the United States and Europe before joining an early-stage, medical diagnostics company as chief financial officer. During her time there, she raised $60 million and completed eight international acquisitions. The company was listed on both the London and Oslo stock exchanges.
Jane then worked with two venture-backed companies. She joined the founders of an online travel company as CEO, and took it from startup to the world's second-largest hotel booking site before Travelocity acquired it. At the request of her venture investors, Jane then joined a computer games developer as CEO and turned around the faltering enterprise before it was sold to a NASDAQ-listed games company.
Most recently, Jane was CEO of an oncology-focused clinical research company, which grew from startup to a multinational firm with $15 million in annual revenue and offices across Europe and the United States. The company was financed through its own cash flow and was sold in early 2012 to a larger clinical research organization.
Jane continues to work with fast growing companies - in interim and full-time positions - as a consultant, board member, and angel investor. In addition, Jane has served on boards for public and private companies, as well as government-related and non-profit organizations. She is a frequent speaker and panelist at conferences, companies, and universities and is an active volunteer in her community. Jane obtained her bachelor's degree from Wake Forest University and her master's degree at the Georgia Institute of Technology.
Schedule a demo today
Want to learn more about OncoLens solutions? Reach out to us and schedule a demo to see how OncoLens can positively impact your workflow.Click Here